IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Resonance Health Limited
Resonance Health is a Public Company that generates the majority of its income from the Diagnostic Imaging Services industry. In 2024 the company generated total revenue of $8,589,000 including sales and other revenue. The exact number of employees for this organisation is not available. The Chief Executive of Resonance Health is Unknown Alison Laws whose official title is CHIEF EXECUTIVE OFFICER. The Chairman of Resonance Health is Dr Martin Blake whose official title is Non-Executive Chairman. Resonance Health Limited is an ASX listed a healthcare company, focused on the development of medical imaging software and services. The company provides the following products to clinicians and pharmaceutical companies: FerriScan FerriSmart HepaFat-Scan HepaFat-AI LiverSmart Cardiac T2
Access this data your way
The Resonance Health Limited Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the Resonance Health Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
Resonance Health Limited, trading as Resonance Health, operates under the ABN 96 006 762 492 and was incorporated on 19 May 1987. Resonance Health Limited trades on the Australian Securities Exchange under the ticker code ASX:RHT. Resonance Health Limited primarily operates in the Scientific Research Services industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within Resonance Health Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents Resonance Health Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Resonance Health Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of Resonance Health Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Industries of Operation
What’s included in the Industries of Operation chapter?
The Industries of Operation chapter outlines Resonance Health Limited’s market share across the industries in which it operates. Each industry profile includes a comprehensive overview featuring data on total market size, the number of enterprises, industry concentration levels, and overall turnover. This analysis provides context for the company’s competitive position and scale within each relevant market.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of Resonance Health Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Resonance Health Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of Resonance Health Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is Resonance Health Limited?
Resonance Health Limited is an ASX listed a healthcare company, focused on the development of medical imaging software and services. The company provides the following products to clinicians and pharmaceutical companies: FerriScan FerriSmart HepaFat-Scan HepaFat-AI LiverSmart Cardiac T2
What industry does Resonance Health Limited operate in?
Resonance Health Limited, trading as Resonance Health, is a Public Company that generates the majority of its income from the Scientific Research Services industry in Australia.
Where is Resonance Health Limited located?
Murray Cod Australia Limited company is based at 141 Burswood Road, Burswood, Western Australia, Australia.
Who is the CEO of Resonance Health Limited?
The FINANCIAL DECISION MAKER of Resonance Health Limited is Alison Laws and the FINANCIAL DECISION MAKER is Agha Shahzad.
What was Resonance Health Limited’s revenue in 2025?
In 2025, Resonance Health Limited generated total revenue of approximately $8.6 million.
Cut through the noise with intelligence you can trust
